Efficacy and safety of single-dose antiviral drugs for influenza treatment: A systematic review and network meta-analysis.

Zhao, Yonghong; Huang, Guangliang; He, Wenjuan; Sun, Qian; Zhao, Xiaojuan; Li, Dan; Wang, Huichao; Cui, Wenyan; Liu, Xiuju

Zhao, Yonghong; Huang, Guangliang; He, Wenjuan; Sun, Qian; Zhao, Xiaojuan; Li, Dan; Wang, Huichao; Cui, Wenyan; Liu, Xiuju.

Afiliação

Zhao Y; The Second Hospital of HeBei Medical University, Shijiazhuang, China.
Huang G; The Second Hospital of HeBei Medical University, Shijiazhuang, China.
He W; The Second Hospital of HeBei Medical University, Shijiazhuang, China.
Sun Q; The Second Hospital of HeBei Medical University, Shijiazhuang, China.
Zhao X; The Second Hospital of HeBei Medical University, Shijiazhuang, China.
Li D; The Second Hospital of HeBei Medical University, Shijiazhuang, China.
Wang H; The Second Hospital of HeBei Medical University, Shijiazhuang, China.
Cui W; The Second Hospital of HeBei Medical University, Shijiazhuang, China.
Liu X; The Second Hospital of HeBei Medical University, Shijiazhuang, China.

J Med Virol ; 94(7): 3270-3302, 2022 07.

Article em En | MEDLINE | ID: mdl-35315516

Assuntos

Antipiréticos; Influenza Humana; Humanos; Antipiréticos/uso terapêutico; Antivirais/efeitos adversos; Influenza Humana/tratamento farmacológico; Metanálise em Rede

Palavras-chave

antiviral drugs; efficacy; influenza; network meta-analysis; safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Influenza Humana / Antipiréticos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Med Virol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google